- |||||||||| ICT-121 / EOM Pharma
Trial completion, Trial completion date, Trial primary completion date: A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma (clinicaltrials.gov) - Aug 13, 2018 P1, N=20, Completed, Active, not recruiting --> Completed | Trial completion date: Nov 2018 --> Mar 2017 | Trial primary completion date: Nov 2017 --> Mar 2017
- |||||||||| ICT-121 / EOM Pharma
Enrollment closed: A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma (clinicaltrials.gov) - Sep 22, 2016 P1, N=20, Active, not recruiting, Active, not recruiting --> Completed | Trial completion date: Nov 2018 --> Mar 2017 | Trial primary completion date: Nov 2017 --> Mar 2017 Recruiting --> Active, not recruiting
|